Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Shareholders' Equity

v3.21.1
Condensed Consolidated Statements of Changes in Shareholders' Equity - USD ($)
shares in Thousands, $ in Millions
Total
Cumulative Effect, Period of Adoption, Adjustment
Preferred Stock
Common Stock
Capital Surplus
Treasury Stock
Accumulated Other Comprehensive Gain (Loss)
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Balance, beginning of period at Dec. 31, 2019 $ 11,795 $ (306) $ 1,203 $ 10 $ 8,806 $ (56) $ (256) $ 2,088 $ (306)
Balance, beginning of period (in shares) at Dec. 31, 2019       1,024,541   (4,537)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income 48             48  
Other comprehensive income (loss), net of tax 483           483    
Repurchases of common stock (in shares)       (7,088)          
Repurchase of common stock (88)       (88)        
Cash dividends declared:                  
Common (155)             (155)  
Preferred (18)             (18)  
Recognition of the fair value of share-based compensation 15       15        
Other share-based compensation activity (in shares)       1,299          
Other share-based compensation activity (5)       (5)        
Other (in shares)           3      
Balance, end of period at Mar. 31, 2020 11,769   1,203 $ 10 8,728 $ (56) 227 1,657  
Balance, end of period (in shares) at Mar. 31, 2020       1,018,752   (4,534)      
Balance, beginning of period at Dec. 31, 2020 12,993   2,191 $ 10 8,781 $ (59) 192 1,878  
Balance, beginning of period (in shares) at Dec. 31, 2020       1,022,258   (5,062)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income 532             532  
Other comprehensive income (loss), net of tax (248)           (248)    
Net proceeds from issuance of Series H Preferred Stock 485   485            
Cash dividends declared:                  
Common (156)             (156)  
Preferred (31)             (31)  
Recognition of the fair value of share-based compensation 28       28        
Other share-based compensation activity (in shares)       836          
Other share-based compensation activity (3)       (3)        
Other (in shares)           21      
Balance, end of period at Mar. 31, 2021 $ 13,600   $ 2,676 $ 10 $ 8,806 $ (59) $ (56) $ 2,223  
Balance, end of period (in shares) at Mar. 31, 2021       1,023,094   (5,041)